Allopregnanolone Produkte
(Allopregnanolone)
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Empfohlene Allopregnanolone Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Applikation
WB, ELISA
Validierungen
Kat. Nr.
ABIN3180922
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Various Species
Applikation
ELISA, CLIA, ICC, IHC (fro)
Validierungen
Kat. Nr.
ABIN7428068
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Applikation
IP, EIA
Validierungen
Kat. Nr.
ABIN546064
Menge
150 μg
Datenblatt
Datenblatt
Empfohlene Allopregnanolone ELISA Kits
Produkt
Reaktivität
Analytical Method
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Various Species
Analytical Method
Quantitative Competition ELISA
Validierungen
- (1)
- (1)
Kat. Nr.
ABIN6964736
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Various Species
Analytical Method
Quantitative Competition ELISA
Validierungen
- (2)
- (1)
Kat. Nr.
ABIN6953620
Menge
96 tests
Datenblatt
Datenblatt
Reaktivität
Human
Analytical Method
Quantitative Competition ELISA
Validierungen
- (1)
Kat. Nr.
ABIN6964735
Menge
96 tests
Datenblatt
Datenblatt
Neueste Publikationen zu unseren Allopregnanolone Produkten
: "Brain allopregnanolone induces marked scratching behaviour in diet-induced atopic dermatitis mouse model." in: Scientific reports, Vol. 9, Issue 1, pp. 2364, (2019) (PubMed).: "Alleviation of Mechanical Allodynia by 14,15-Epoxyeicosatrienoic Acid in a Central Poststroke Pain Model: Possible Role of Allopregnanolone and δ-Subunit-Containing Gamma-Aminobutyric Acid A ..." in: The journal of pain : official journal of the American Pain Society, (2018) (PubMed).
: "The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis." in: Biochimica et biophysica acta, Vol. 1863, Issue 12, pp. 3016-3027, (2017) (PubMed).
: "Decrease in endogenous brain allopregnanolone induces autism spectrum disorder (ASD)-like behavior in mice: A novel animal model of ASD." in: Behavioural brain research, Vol. 334, pp. 6-15, (2017) (PubMed).
: "Replication of Epigenetic Postpartum Depression Biomarkers and Variation with Hormone Levels." in: Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, Vol. 41, Issue 6, pp. 1648-58, (2016) (PubMed).
: "Maternal care and affective behavior in female offspring: Implication of the neurosteroid/GABAergic system." in: Psychoneuroendocrinology, Vol. 76, pp. 29-37, (2016) (PubMed).
: "Antidepressant-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa) in chronically stressed rats." in: Neuropharmacology, Vol. 113, Issue Pt A, pp. 567-575, (2016) (PubMed).
: "TSPO ligand PK11195 alleviates neuroinflammation and beta-amyloid generation induced by systemic LPS administration." in: Brain research bulletin, Vol. 121, pp. 192-200, (2016) (PubMed).
: "Over-expression of TSPO in the hippocampal CA1 area alleviates cognitive dysfunction caused by lipopolysaccharide in mice." in: Brain research, Vol. 1646, pp. 402-9, (2016) (PubMed).
: "Inhibitory respiratory responses to progesterone and allopregnanolone in newborn rats chronically treated with caffeine." in: The Journal of physiology, Vol. 594, Issue 2, pp. 373-89, (2016) (PubMed).
Sie sind hier:
